ImmunityBio Reports Third-Quarter 2024 Financial Results
IBRX Stock | USD 2.50 0.01 0.40% |
Slightly above 55% of Immunitybio's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Immunitybio suggests that some traders are interested. Immunitybio's investing sentiment can be driven by a variety of factors including economic data, Immunitybio's earnings reports, geopolitical events, and overall market trends.
Immunitybio | Build AI portfolio with Immunitybio Stock |
ImmunityBio, Inc. today announced its financial results for the third-quarter ended September 30, 2024. ANKTIVA received a J-code HCP
Read at businesswire.com
![]() |
Immunitybio Current Investor Sentiment
Comfort Level 55
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Immunitybio's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Immunitybio.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentAcquiring |
Immunitybio Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Immunitybio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Immunitybio Historical Investor Sentiment
Investor biases related to Immunitybio's public news can be used to forecast risks associated with an investment in Immunitybio. The trend in average sentiment can be used to explain how an investor holding Immunitybio can time the market purely based on public headlines and social activities around Immunitybio. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Immunitybio's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Immunitybio and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Immunitybio news discussions. The higher the estimate score, the more favorable the investor's outlook on Immunitybio.
Immunitybio Fundamental Analysis
We analyze Immunitybio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immunitybio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immunitybio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Immunitybio is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Immunitybio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immunitybio stock to make a market-neutral strategy. Peer analysis of Immunitybio could also be used in its relative valuation, which is a method of valuing Immunitybio by comparing valuation metrics with similar companies.
Peers
Immunitybio Related Equities
PLX | Protalix Biotherapeutics | 13.70 | ||||
PDSB | PDS Biotechnology | 3.94 | ||||
BLRX | BioLineRx | 3.24 | ||||
PPCB | Propanc Biopharma | 1.82 | ||||
XFOR | X4 Pharmaceuticals | 0.30 | ||||
TGTX | TG Therapeutics | 0.33 | ||||
ARDX | Ardelyx | 1.18 | ||||
ELEV | Elevation Oncology | 2.20 | ||||
KRYS | Krystal Biotech | 3.51 | ||||
MDGL | Madrigal Pharmaceuticals | 4.03 | ||||
VKTX | Viking Therapeutics | 4.87 | ||||
CVAC | CureVac NV | 6.08 | ||||
MCRB | Seres Therapeutics | 11.17 | ||||
VIR | Vir Biotechnology | 11.32 | ||||
LXRX | Lexicon Pharmaceuticals | 12.70 |
Additional Tools for Immunitybio Stock Analysis
When running Immunitybio's price analysis, check to measure Immunitybio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunitybio is operating at the current time. Most of Immunitybio's value examination focuses on studying past and present price action to predict the probability of Immunitybio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunitybio's price. Additionally, you may evaluate how the addition of Immunitybio to your portfolios can decrease your overall portfolio volatility.